logo
Select company
Select metric
$ -1.87MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
41
Sector
46
Industry
49
History
53
$ 1.29Close
$ 1.06 - $ 2.55 52-Week Range
Ticker Information

Ticker

HRTX

Company Name

HERON THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

HERON THERAPEUTICS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HRTX - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -1.87M
3/31/2025$ -1.18M
12/31/2024$ -2.88M
9/30/2024$ -9.12M
6/30/2024$ 4.92M
3/31/2024$ -6.64M
12/31/2023$ 13.31M
9/30/2023$ -15.58M
6/30/2023$ -35.15M
3/31/2023$ -29.82M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HERON THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 35.03M.
  • Over the past 5 years, HERON THERAPEUTICS INC's average CF - Chg. Cash has been $ -11.43M.
  • The median CF - Chg. Cash for HERON THERAPEUTICS INC during this period was $ -4.76M
  • HERON THERAPEUTICS INC reached its highest CF - Chg. Cash over the past 5 years at $ 110.44M.
  • The lowest CF - Chg. Cash recorded by HERON THERAPEUTICS INC in the same timeframe $ -142.56M

HERON THERAPEUTICS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
GLUE : MONTE ROSA THERAPEUTICS INC $ -39.33MCHRS : COHERUS ONCOLOGY INC $ 57.46MTRDA : ENTRADA THERAPEUTICS INC $ -112.77MMGNX : MACROGENICS INC $ 46.75MVNDA : VANDA PHARMACEUTICALS INC $ -21.97MAGEN : AGENUS INC $ -84.19MIGMS : IGM BIOSCIENCES INC $ -36.61MOSUR : ORASURE TECHNOLOGIES INC $ -23.66MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -63.86MALEC : ALECTOR INC $ -2.47M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

HRTX - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -142.56M

Minimum

Jun 30, 2022

$ 110.44M

Maximum

Jun 30, 2021

$ -11.43M

Average

$ -4.76M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M